What is the impact factor of clinical cancer research?

12.53Clinical Cancer Research / Impact Factor (2021)

Is clinical cancer research a good journal?

The overall rank of Clinical Cancer Research is 338. According to SCImago Journal Rank (SJR), this journal is ranked 4.399.

What is the impact factor of cancer?

Endocrine-Related Cancer’s 2020 Impact Factor has risen to 5.678, with the five-year measure now standing at 6.169. This increase in Impact Factor reflects the high-quality research identified by the Editorial Board, their hard work to ensure the upmost quality, and strong leadership.

Is Cancer Letters A good journal?

The overall rank of Cancer Letters is 1335. According to SCImago Journal Rank (SJR), this journal is ranked 1.923. SCImago Journal Rank is an indicator, which measures the scientific influence of journals.

What is the impact factor of journal of Clinical Oncology?

44.54Journal of Clinical Oncology / Impact Factor (2020)
JCO’s Impact Factor is 44.544 as reported by Clarivate in its 2020 Journal Citation Reports. J. Clin. Oncol.

Is oncogene a good journal?

According to the Journal Citation Reports, the journal received a 2019 impact factor of 7.971, ranking it 29th out of 297 journals (9.596%) in the category Biochemistry & Molecular Biology, 26th out of 244 journals (10.451%) in the category Oncology, 31st out of 190 journals (15.641%) in the category Cell Biology, and …

Is MDPI cancers a good journal?

MDPI publishes good papers in good journals, but it also employs some strategies that are proper to predatory publishers.

Is oncogene a high impact journal?

Is MDPI still a predatory publisher?

Therefore, the conclusion that MDPI journals are predatory does not follow. We have taken the opportunity to analyse self-citation data across different publishers. Figure 1 represents publishers with more than 10,000 publications between 2018 and July 2021.